| Bid Price | 6.20p | High Price | 6.70p |
|---|
| Ask Price | 6.40p | Low Price | 6.20p |
|---|
| Open Price | 6.30p | Spread | 3.13% |
|---|
| Prev Close | 6.30p | Volume | 215,289 |
|---|
Fusion Antibodies PLC Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Jun 27, 2025 | 6.30 | 6.70 | 6.20 | 6.30 | 215,289 |
| Jun 26, 2025 | 6.30 | 6.69 | 6.20 | 6.30 | 246,971 |
| Jun 25, 2025 | 6.45 | 6.70 | 6.20 | 6.30 | 298,583 |
| Jun 24, 2025 | 6.30 | 6.70 | 6.20 | 6.45 | 568,407 |
| Jun 23, 2025 | 6.45 | 6.67 | 6.20 | 6.30 | 680,233 |
Fusion Antibodies PLC Information
| Name | Fusion Antibodies PLC | Index | |
|---|
| ISIN | GB00BDQZGK16 | Epic | FAB |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | ASQ1 |
|---|
| Industry | Biotechnology | Sector | Healthcare |
|---|
| EMS | 30,000 | Trading Status | Closed |
|---|
| Shares in Issue | 113.66 m | Prev Close | 6.30p |
|---|
| PE Ratio | | Market Cap | £7.16 m |
|---|
| Div Yield | 0 | Div per Share | £NaN |
|---|
| EPS | -£0.01 | Div Cover | NaN |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | -0.519244 | DPS Growth (%) | 0 |
|---|
| Current Ratio | 3.252273 | Quick Ratio | 2.729545 |
|---|
Fusion Antibodies PLC Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 12/05/25 | LOF | Colin Walsh | NED | 221,311 @ £0.06 | £13,500.00 |
| 12/05/25 | LOF | Simon Douglas | CH | 61,475 @ £0.06 | £3,750.00 |
| 12/05/25 | LOF | Matthew Baker | NED | 55,327 @ £0.06 | £3,375.00 |
| 06/05/25 | BUY | Adrian Kinkaid | CEO | 100,000 @ £0.06 | £6,180.00 |
| 22/10/24 | LOF | Colin Walsh | NED | 325,301 @ £0.04 | £13,500.00 |
| 22/10/24 | LOF | Simon Douglas | CH | 180,722 @ £0.04 | £7,500.00 |
| 22/10/24 | LOF | Matthew Baker | NED | 81,325 @ £0.04 | £3,375.00 |
| 16/10/24 | BUY | Adrian Kinkaid | CEO | 83,728 @ £0.04 | £3,504.00 |
| 09/09/24 | BUY | Richard Buick | ED | 94,825 @ £0.03 | £3,106.00 |
| 05/09/24 | BUY | Adrian Kinkaid | CEO | 120,000 @ £0.03 | £3,804.00 |
Fusion Antibodies PLC News
